Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL217782 | 0.97 | CA1 (0.33) | CA1CA2CA4CA12CA7 | |
| Phosphine SCHEMBL28955379 | 0.94 | CA1 (0.32) | CA1CA2CA4CA12CA7 | |
| SCHEMBL23848350 | 0.92 | CA1 (0.31) | CA1CA2CA4CA12CA7 | |
| Benzene SCHEMBL28371694 | 0.92 | CA1 (0.31) | CA1CA2CA4CA12CA7 | |
| Trimethylammonium SCHEMBL367682 | 0.87 | — | — | |
| Dimethylamine SCHEMBL7085212 | 0.87 | — | — | |
| Trimethylammonium SCHEMBL29552092 | 0.87 | — | — | |
| SCHEMBL29558198 | 0.85 | — | — | |
| Tert-Butylamine SCHEMBL2827496 | 0.84 | — | — | |
| Ethylamine SCHEMBL7256955 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190256630-A1 | Group 6 Transition Metal Catalyst Compound and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190256630-A1 | Group 6 Transition Metal Catalyst Compound and Use Thereof | MCM6, PGR, MCM4 | CA1 729/4885CA2 1648/4885CA4 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.